Ligand validation:3HYV

PS9: octathiocane

PS9 is a Ligand Of Interest in 3HYV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HYV_PS9_A_800	1%	39%	0.442	0.661	0.87	1.48	-	2	2	0	100%	0.3
3HYV_PS9_E_800	1%	46%	0.46	0.637	0.82	1.27	-	-	0	0	100%	0.3
3HYV_PS9_F_800	1%	44%	0.484	0.59	0.86	1.28	-	1	1	0	100%	0.3
3HYV_PS9_B_800	1%	40%	0.506	0.656	1.62	0.75	-	-	2	0	75%	0.225
3HYV_PS9_C_800	0%	32%	0.431	0.483	1.63	1.1	-	-	1	0	75%	0.225
3HYV_PS9_D_802	0%	26%	0.95	0.47	1.63	1.4	-	-	1	0	63%	18.75
3HYX_PS9_C_800	1%	48%	0.535	0.733	0.88	1.11	-	-	2	0	100%	0.3
3HYW_PS9_F_800	1%	44%	0.504	0.647	0.87	1.27	-	-	2	0	100%	0.3
5JR5_PS9_A_101	70%	54%	0.103	0.919	1.07	0.71	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.